Literature DB >> 33087562

Blocking PPARγ interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression.

Peng-Bo Yang1, Pei-Pei Hou1, Fu-Yuan Liu1, Wen-Bin Hong1, Hang-Zi Chen1, Xiao-Yu Sun1, Peng Li1, Yi Zhang1, Cui-Yu Ju1, Li-Juan Luo1, Sheng-Fu Wu1, Jia-Xin Zhou1, Zhi-Jing Wang1, Jian-Ping He1, Li Li1, Tong-Jin Zhao1, Xianming Deng1, Tianwei Lin2, Qiao Wu2.   

Abstract

Nuclear receptor Nur77 participates in multiple metabolic regulations and plays paradoxical roles in tumorigeneses. Herein, we demonstrated that the knockout of Nur77 stimulated mammary tumor development in two mouse models, which would be reversed by a specific reexpression of Nur77 in mammary tissues. Mechanistically, Nur77 interacted and recruited corepressors, the SWI/SNF complex, to the promoters of CD36 and FABP4 to suppress their transcriptions, which hampered the fatty acid uptake, leading to the inhibition of cell proliferation. Peroxisome proliferator-activated receptor-γ (PPARγ) played an antagonistic role in this process through binding to Nur77 to facilitate ubiquitin ligase Trim13-mediated ubiquitination and degradation of Nur77. Cocrystallographic and functional analysis revealed that Csn-B, a Nur77-targeting compound, promoted the formation of Nur77 homodimer to prevent PPARγ binding by steric hindrance, thereby strengthening the Nur77's inhibitory role in breast cancer. Therefore, our study reveals a regulatory function of Nur77 in breast cancer via impeding fatty acid uptake.

Entities:  

Keywords:  breast cancer; cytosporone-B; fatty acid uptake; nuclear receptors Nur77 and PPARγ; ubiquitination

Mesh:

Substances:

Year:  2020        PMID: 33087562      PMCID: PMC7959534          DOI: 10.1073/pnas.2002997117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  Current management of lesions associated with an increased risk of breast cancer.

Authors:  Monica Morrow; Stuart J Schnitt; Larry Norton
Journal:  Nat Rev Clin Oncol       Date:  2015-01-27       Impact factor: 66.675

2.  Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.

Authors:  Clinton D Allred; Michael W Kilgore
Journal:  Mol Cell Endocrinol       Date:  2005-03-16       Impact factor: 4.102

3.  Orphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathway.

Authors:  Wei-jia Wang; Yuan Wang; Hang-zi Chen; Yong-zhen Xing; Feng-wei Li; Qian Zhang; Bo Zhou; Hong-kui Zhang; Jie Zhang; Xue-li Bian; Li Li; Yuan Liu; Bi-xing Zhao; Yan Chen; Rong Wu; An-zhong Li; Lu-ming Yao; Ping Chen; Yi Zhang; Xu-yang Tian; Friedrich Beermann; Mian Wu; Jiahuai Han; Pei-qiang Huang; Tianwei Lin; Qiao Wu
Journal:  Nat Chem Biol       Date:  2013-12-08       Impact factor: 15.040

4.  Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion.

Authors:  Béatrice Dirat; Ludivine Bochet; Marta Dabek; Danièle Daviaud; Stéphanie Dauvillier; Bilal Majed; Yuan Yuan Wang; Aline Meulle; Bernard Salles; Sophie Le Gonidec; Ignacio Garrido; Ghislaine Escourrou; Philippe Valet; Catherine Muller
Journal:  Cancer Res       Date:  2011-04-01       Impact factor: 12.701

5.  The orphan receptor TR3 suppresses intestinal tumorigenesis in mice by downregulating Wnt signalling.

Authors:  Hang-Zi Chen; Qing-Feng Liu; Li Li; Wei-Jia Wang; Lu-Ming Yao; Meng Yang; Bo Liu; Wei Chen; Yan-Yan Zhan; Ming-Qing Zhang; Jian-Chun Cai; Zhong-hui Zheng; Sheng-Cai Lin; Bo-An Li; Qiao Wu
Journal:  Gut       Date:  2011-08-28       Impact factor: 23.059

6.  Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival.

Authors:  Véronique Chajès; Marie Cambot; Karen Moreau; Gilbert M Lenoir; Virginie Joulin
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

7.  Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy.

Authors:  Mengjie Hu; Qiang Luo; Gulimiran Alitongbieke; Shuyi Chong; Chenting Xu; Lei Xie; Xiaohui Chen; Duo Zhang; Yuqi Zhou; Zhaokai Wang; Xiaohong Ye; Lijun Cai; Fang Zhang; Huibin Chen; Fuquan Jiang; Hui Fang; Shanjun Yang; Jie Liu; Maria T Diaz-Meco; Ying Su; Hu Zhou; Jorge Moscat; Xiangzhi Lin; Xiao-Kun Zhang
Journal:  Mol Cell       Date:  2017-04-06       Impact factor: 17.970

Review 8.  Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.

Authors:  Javier A Menendez; Ruth Lupu
Journal:  Nat Rev Cancer       Date:  2007-10       Impact factor: 60.716

9.  Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia.

Authors:  Shannon E Mullican; Shuo Zhang; Marina Konopleva; Vivian Ruvolo; Michael Andreeff; Jeffrey Milbrandt; Orla M Conneely
Journal:  Nat Med       Date:  2007-05-21       Impact factor: 53.440

10.  Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance.

Authors:  Maura Agostini; Erik Schoenmakers; Catherine Mitchell; Istvan Szatmari; David Savage; Aaron Smith; Odelia Rajanayagam; Robert Semple; Jian'an Luan; Louise Bath; Anthony Zalin; Mourad Labib; Sudhesh Kumar; Helen Simpson; Dirk Blom; David Marais; John Schwabe; Inês Barroso; Richard Trembath; Nicholas Wareham; Laszlo Nagy; Mark Gurnell; Stephen O'Rahilly; Krishna Chatterjee
Journal:  Cell Metab       Date:  2006-10       Impact factor: 27.287

View more
  16 in total

Review 1.  CD36: an emerging therapeutic target for cancer and its molecular mechanisms.

Authors:  Chengwei Ruan; Yankai Meng; Hu Song
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-27       Impact factor: 4.553

Review 2.  Nuclear Receptor Coregulators in Hormone-Dependent Cancers.

Authors:  Hedieh Jafari; Shahid Hussain; Moray J Campbell
Journal:  Cancers (Basel)       Date:  2022-05-13       Impact factor: 6.575

3.  NR4A1 agonist cytosporone B attenuates neuroinflammation in a mouse model of multiple sclerosis.

Authors:  Hai-Zhen Yu; Bing-Qing Zhu; Lin Zhu; Shuo Li; Li-Mei Wang
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

4.  Loss of Lipocalin 10 Exacerbates Diabetes-Induced Cardiomyopathy via Disruption of Nr4a1-Mediated Anti-Inflammatory Response in Macrophages.

Authors:  Qianqian Li; Yutian Li; Wei Huang; Xiaohong Wang; Zhenling Liu; Jing Chen; Yanbo Fan; Tianqing Peng; Sakthivel Sadayappan; Yigang Wang; Guo-Chang Fan
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

5.  NR4A Family Genes: A Review of Comprehensive Prognostic and Gene Expression Profile Analysis in Breast Cancer.

Authors:  Hassan Yousefi; Jordyn Fong; Suresh K Alahari
Journal:  Front Oncol       Date:  2022-04-25       Impact factor: 5.738

Review 6.  Targeting NR4A Nuclear Receptors to Control Stromal Cell Inflammation, Metabolism, Angiogenesis, and Tumorigenesis.

Authors:  Daniel Crean; Evelyn P Murphy
Journal:  Front Cell Dev Biol       Date:  2021-02-09

7.  PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective.

Authors:  M Lizeth Orozco Morales; Catherine A Rinaldi; Emma de Jong; Sally M Lansley; Joel P A Gummer; Bence Olasz; Shabarinath Nambiar; Danika E Hope; Thomas H Casey; Y C Gary Lee; Connull Leslie; Gareth Nealon; David M Shackleford; Andrew K Powell; Marina Grimaldi; Patrick Balaguer; Rachael M Zemek; Anthony Bosco; Matthew J Piggott; Alice Vrielink; Richard A Lake; W Joost Lesterhuis
Journal:  iScience       Date:  2021-12-04

Review 8.  How cancer cells remodel lipid metabolism: strategies targeting transcription factors.

Authors:  Do-Won Jeong; Seulbee Lee; Yang-Sook Chun
Journal:  Lipids Health Dis       Date:  2021-11-14       Impact factor: 3.876

9.  The initial expression alterations occurring to transcription factors during the formation of breast cancer: Evidence from bioinformatics.

Authors:  Xingxing Dong; Yalong Yang; Gaoran Xu; Zelin Tian; Qian Yang; Yan Gong; Gaosong Wu
Journal:  Cancer Med       Date:  2022-01-17       Impact factor: 4.452

10.  PPARγ Mediates the Anti-Epithelial-Mesenchymal Transition Effects of FGF1ΔHBS in Chronic Kidney Diseases via Inhibition of TGF-β1/SMAD3 Signaling.

Authors:  Dezhong Wang; Tianyang Zhao; Yushuo Zhao; Yuan Yin; Yuli Huang; Zizhao Cheng; Beibei Wang; Sidan Liu; Minling Pan; Difei Sun; Zengshou Wang; Guanghui Zhu
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.